This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.49, moving +1.06% from the previous trading session.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $46.99, marking a -0.72% move from the previous day.
Altria (MO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Stock Moves -0.46%: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.27, moving -0.46% from the previous trading session.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.49, moving +0.19% from the previous trading session.
Altria (MO) to Divest Ste. Michelle Wine Estates Business
by Zacks Equity Research
Altria's (MO) subsidiary agrees to sell Ste. Michelle Wine Estates business. The move will boost shareholders' value, while aiding in smooth transition of adult smokers to a non-combustible future.
Company News for Jul 12, 2021
by Zacks Equity Research
Companies In The News Are: LEVI, PM, UAL, MO
Altria (MO) Up 14% in 6 Months, Gains on Low-Risk Products
by Zacks Equity Research
Altria's (MO) low-risk tobacco offerings such as IQOS and on! are gaining popularity. Moreover, strong pricing for tobacco products is an upside.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $47.53 in the latest trading session, marking a -0.63% move from the prior day.
Top Stock Reports for Pfizer, Qualcomm & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), QUALCOMM (QCOM), and Philip Morris International (PM).
Philip Morris (PM) Up 10% in 3 Months, Gains on Pricing & RRPs
by Zacks Equity Research
Philip Morris (PM) is gaining from rising popularity of IQOS devices. Additionally, pricing power, especially for combustible products, is an upside.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $46.78, moving -0.85% from the previous trading session.
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $47.02 in the latest trading session, marking a -0.47% move from the prior day.
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $46.87, marking a -1.06% move from the previous day.
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.90, moving -0.37% from the previous trading session.
Altria (MO) Gains on Low-Risk Tobacco Offerings, Strong Pricing
by Zacks Equity Research
Altria's (MO) low-risk and oral tobacco offerings are gaining popularity. Moreover, high pricing for tobacco products is an upside.
Zacks Industry Outlook Highlights: Vector Group, Philip Morris International and Altria Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Vector Group, Philip Morris International and Altria Group
Top Stock Reports for Mastercard, Netflix & QUALCOMM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Netflix (NFLX), and QUALCOMM (QCOM).
3 Tobacco Stocks to Watch on Rising RRPs Demand & Pricing Gains
by Vidya Nair
Solid pricing as well as growth in low-risk tobacco alternatives are favoring performance of tobacco players such as Philip Morris (PM), Altria (MO) and Vector Group (VGR).
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $49.90, marking a +0.04% move from the previous day.
Zacks Industry Outlook Highlights: Philip Morris, Altria Group and Vector Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Philip Morris, Altria Group and Vector Group
3 Tobacco Stocks to Watch for Gains in a Challenging Industry
by Zacks Equity Research
The Zacks Tobacco industry grapples with low cigarette sales volumes. Nevertheless, solid pricing is a boon for a number of tobacco companies such as Philip Morris (PM), Altria (MO) and Vector Group (VGR).
Campbell Soup (CPB) Queued for Q3 Earnings: Things to Note
by Zacks Equity Research
Campbell Soup's (CPB) third-quarter fiscal 2021 results are likely to reflect the impact of supply challenges stemming from winter storms.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $49.78 in the latest trading session, marking a +0.55% move from the prior day.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $49.51, marking a +0.3% move from the previous day.